Cargando…

Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening

BACKGROUND: Between 2003 and 2010 digital mammography (DM) gradually replaced screen-film mammography (SFM) in the Dutch breast cancer screening programme (BCSP). Previous studies showed increases in detection rate (DR) after the transition to DM. However, national interval cancer rates (ICR) have n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sankatsing, Valérie D. V., Fracheboud, Jacques, de Munck, Linda, Broeders, Mireille J. M., van Ravesteyn, Nicolien T., Heijnsdijk, Eveline A. M., Verbeek, André L. M., Otten, Johannes D. M., Pijnappel, Ruud M., Siesling, Sabine, de Koning, Harry J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839006/ https://www.ncbi.nlm.nih.gov/pubmed/29506487 http://dx.doi.org/10.1186/s12885-018-4122-2

Ejemplares similares

Interpreting Overdiagnosis Estimates in Population-based Mammography Screening
por: de Gelder, Rianne, et al.
Publicado: (2011)

Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modelled strategies
por: Kregting, Lindy M., et al.
Publicado: (2022)

Reply to: Comments on “Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modeled strategies”
por: Kregting, Lindy M., et al.
Publicado: (2022)

Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers
por: de Munck, Linda, et al.
Publicado: (2016)

Decreased rates of advanced breast cancer due to mammography screening in The Netherlands
por: Fracheboud, J, et al.
Publicado: (2004)

Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy
por: Zielonke, Nadine, et al.
Publicado: (2023)

Impact of mammographic screening and advanced cancer definition on the percentage of advanced-stage cancers in a steady-state breast screening programme in the Netherlands
por: de Munck, Linda, et al.
Publicado: (2020)

Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals
por: van Ravesteyn, N T, et al.
Publicado: (2011)

Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios
por: Zielonke, Nadine, et al.
Publicado: (2021)

The potential of breast cancer screening in Europe
por: Zielonke, Nadine, et al.
Publicado: (2020)

Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue
por: Geuzinge, H Amarens, et al.
Publicado: (2021)

Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk
por: Geuzinge, H. Amarens, et al.
Publicado: (2021)

Interval cancers in the Dutch breast cancer screening programme
por: Fracheboud, J, et al.
Publicado: (1999)

Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening
por: Duijm, L E M, et al.
Publicado: (2004)

Reply: Flawed methods explain the effect of mammography screening in Nijmegen
por: Verbeek, A L M, et al.
Publicado: (2011)

Immediate and delayed effects of mammographic screening on breast cancer mortality and incidence in birth cohorts
por: Ripping, T M, et al.
Publicado: (2013)

Delayed breast cancer diagnosis after repeated recall at biennial screening mammography: an observational follow-up study from the Netherlands
por: Lameijer, Joost R. C., et al.
Publicado: (2020)

Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic
por: Eijkelboom, Anouk H., et al.
Publicado: (2021)

Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths
por: de Gelder, R, et al.
Publicado: (2011)

Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, Lindy M., et al.
Publicado: (2021)

The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening
por: van Luijt, P. A., et al.
Publicado: (2016)

Correction: Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, Lindy M., et al.
Publicado: (2021)

Cost‐effectiveness of multiparametric magnetic resonance imaging and MRI‐guided biopsy in a population‐based prostate cancer screening setting using a micro‐simulation model
por: Getaneh, Abraham M., et al.
Publicado: (2021)

Inter-observer variability in mammography screening and effect of type and number of readers on screening outcome
por: Duijm, L E M, et al.
Publicado: (2009)

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality
por: Chang, Yaojen, et al.
Publicado: (2012)

The dilemma of recalling well-circumscribed masses in a screening population: A narrative literature review and exploration of Dutch screening practice
por: Geertse, Tanya D., et al.
Publicado: (2023)

Effect of screening mammography on breast cancer mortality: Quasi‐experimental evidence from rollout of the Dutch population‐based program with 17‐year follow‐up of a cohort
por: Van Ourti, Tom, et al.
Publicado: (2019)

Volumetric breast density affects performance of digital screening mammography
por: Wanders, Johanna O. P., et al.
Publicado: (2016)

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
por: Getaneh, Abraham M., et al.
Publicado: (2020)

The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe
por: Gini, Andrea, et al.
Publicado: (2021)

Which Strategies Reduce Breast Cancer Mortality Most?: Collaborative Modeling of Optimal Screening, Treatment, and Obesity Prevention
por: Mandelblatt, Jeanne, et al.
Publicado: (2013)

Screening for cancers with a good prognosis: The case of testicular germ cell cancer
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2021)

Evaluation of reader performance during interpretation of breast cancer screening: the Recall and detection Of breast Cancer in Screening (ROCS) trial study design
por: Sechopoulos, Ioannis, et al.
Publicado: (2022)

Mammography screening interval and the frequency of interval cancers in a population-based screening.
por: Klemi, P. J., et al.
Publicado: (1997)

Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam
por: Wever, Elisabeth M., et al.
Publicado: (2010)

Comparing Visually Assessed BI-RADS Breast Density and Automated Volumetric Breast Density Software: A Cross-Sectional Study in a Breast Cancer Screening Setting
por: van der Waal, Daniëlle, et al.
Publicado: (2015)

Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women
por: van Ravesteyn, Nicolien T, et al.
Publicado: (2021)

Comparison of 1- and 2-year screening intervals for women undergoing screening mammography
por: Wai, E S, et al.
Publicado: (2005)

Geographic variation in volumetric breast density between screening regions in the Netherlands
por: van der Waal, Daniëlle, et al.
Publicado: (2015)

To be screened or not to be screened? Modeling the consequences of PSA screening for the individual
por: Wever, E M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ptstln0j7vjj7gg91hti86gp90